SCHEMBL7288495

SCHEMBL7288495

O=C(Cc1ccccc1)Nc1ccccc1SCc1ccc(Cl)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.70
MEN1 O00255 6/20 0.70
L3MBTL1 Q9Y468 5/20 0.70
LMNA P02545 3/20 0.70
ALDH1A1 P00352 5/20 0.59
HPGD P15428 5/20 0.59
ATM Q13315 1/20 0.59
MAPK1 P28482 2/20 0.55
CYP1A2 P05177 2/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2D6 P10635 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
MCL1 Q07820 1/20 0.54
NPSR1 Q6W5P4 2/20 0.53
TDP1 Q9NUW8 1/20 0.52
KCNQ2 O43526 1/20 0.52
GAA P10253 1/20 0.51
BLM P54132 1/20 0.50
NOD2 Q9HC29 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7300289 0.84 MAPT (0.62) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL7297699 0.81 MEN1 (0.61) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL11357236 0.78 KMT2A (0.51) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL9445665 0.78 L3MBTL1 (0.74) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL8127190 0.75 L3MBTL1 (0.53) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL30117933 0.74 KMT2A (0.77) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL15437984 0.74 KMT2A (0.77) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL10750201 0.74 KMT2A (0.77) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL9370024 0.74 KMT2A (0.77) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL8636891 0.73 NPC1 (0.64) KMT2AMEN1L3MBTL1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116851-A Administering antiischemic and antiarrhythmia agents E. R. SQUIBB & SONS, INC. (US) 1992-05-26 US disclosed
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP disclosed